Pembrolizumab [Keytruda] Decision, (201747022885)
No Annotations
Alert me when there are new annotations for this document
10 similar patent office decisions
-
Brigatinib decision, (3939/KOLNP/2010)
Countries: India Date: 2023
-
Bedaquiline decision, (1220/MUMNP/2009)
Countries: India Date: 2023
-
Bictegravir / Emtricitabine / Tenofovir Alafenamide [Biktarvy] decision, (201817013772)
Countries: India Date: 2023
-
imatinib (ITB) decision, (1602/MAS/98 )
Countries: India Date: 2006
-
sunitinib (su) decision, (IN/PCT/2002/00785/DEL )
Countries: India Date: 2012
-
Paclitaxel decision, (2899/DELNP/2005)
Countries: India Date: 2014
-
Lapatinib decision, (IN221171)
Countries: India Date: 2013
-
Pembrolizumab [KEYTRUDA] decision, (201617025251)
Countries: India Date: 2024
-
Enzalutamide decision, (9668/DELNP/2007 (WO/2006/124118))
Countries: India Date: 2016
-
Enzalutamide decision, (9668/DELNP/2007)
Countries: India Date: 2016